The lack of ADAMTS13 tests is explained by the fact that, despite being necessary to confirm TTP diagnosis, the test is not easily available in the real world, particularly in low- and middle-income countries. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.